Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:1017-1022
Published online before print April 27, 2009, doi: 10.1161/HYPERTENSIONAHA.109.129924
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
53/6/1017    most recent
HYPERTENSIONAHA.109.129924v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Zulli, A.
Right arrow Articles by Hare, D. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zulli, A.
Right arrow Articles by Hare, D. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-METHIONINE
*NITRIC OXIDE
Medline Plus Health Information
*Coronary Artery Disease
*Dietary Supplements
*Diets
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Pathophysiology
Right arrow Chronic ischemic heart disease
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article

(Hypertension. 2009;53:1017.)
© 2009 American Heart Association, Inc.


Original Articles

High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery

Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia

Anthony Zulli; Eza Lau; Bagus P.P. Wijaya; Xin Jin; Komang Sutarga; Grace D. Schwartz; Jonathon Learmont; Peter J. Wookey; Angelo Zinellu; Ciriaco Carru; David L. Hare

From the Departments of Cardiology (A.Z., E.L., B.P.P.W., X.J., K.S., G.D.S., J.L., P.J.W., D.L.H.) and Medicine (A.Z., D.L.H.), University of Melbourne, Austin Health, Heidelberg, Australia; and the Department of Biomedical Sciences (A.Z., C.C.), University of Sassari Viale S Pietro, Sassari, Italy.

Correspondence to Anthony Zulli, Vascular Laboratory, Department of Cardiology, Austin Health, Heidelberg, Australia. E-mail azulli{at}unimelb.edu.au

We sought to determine whether taurine could specifically protect against coronary artery disease during an atherogenic diet and whether taurine affects the lipid profile, metabolites of methionine, and endothelial atherogenic systems. Rabbits were fed one of the following diets for 4 weeks: (1) control diet; (2) 0.5% cholesterol+1.0% methionine; or (3) 0.5% cholesterol+1.0% methionine+2.5% taurine. Endothelial function was examined, and the left main coronary artery atherosclerosis was quantified by stereology and semiquantitative immunohistochemistry to determine the endothelial expression of proteins related to the NO, renin-angiotensin, endoplasmic reticulum, and oxidative stress systems, as well as apoptosis. Taurine normalized hyperhomocysteinemia (P<0.05) and significantly reduced hypermethioninemia (P<0.05) but not lipidemia. The intima:media ratio was reduced by 28% (P=0.034), and atherosclerosis was reduced by 64% (P=0.012) and endothelial cell apoptosis by 30% (P<0.01). Endothelial cell CCAAT/enhancer binding protein homologous protein was normalized (P<0.05). Taurine failed to improve hyperlipidemia, endothelial function, or endothelial proteins related to the NO, renin-angiotensin, and oxidative stress systems. Taurine reduces left main coronary artery wall pathology associated with decreased plasma total homocysteine, methionine, apoptosis, and normalization of CCAAT/enhancer binding protein homologous protein. These results elucidate the antiapoptotic and antiatherogenic properties of taurine, possibly via normalization of endoplasmic reticulum stress.


Key Words: cholesterol • homocysteine • methionine • atherosclerosis • plaque • CHOP


Related Article:

Taurine: Red Bull or Red Herring?
Sebastiaan Wesseling, Maarten P. Koeners, and Jaap A. Joles
Hypertension 2009 53: 909-911. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
S. Wesseling, M. P. Koeners, and J. A. Joles
Taurine: Red Bull or Red Herring?
Hypertension, June 1, 2009; 53(6): 909 - 911.
[Full Text] [PDF]